Characterization of RNA aptamers that disrupt the RUNX1-CBFβ/DNA complex

Nucleic Acids Research

Volumn 37, Issue 20, 2009, Pages 6818-6830

  Barton, Jenny L ^a   Bunka, David H J ^b   Knowling, Stuart E ^b   Lefevre, Pascal ^a   Warren, Alan J ^c,d   Bonifer, Constanze ^a   Stockley, Peter G ^b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; CORE BINDING FACTOR BETA; DNA; DOUBLE STRANDED DNA; RECOMBINANT PROTEIN; RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX1;

ARTICLE; BINDING AFFINITY; CONSENSUS SEQUENCE; DNA PROTEIN COMPLEX; DNA SEQUENCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; BINDING SITE; CHEMISTRY; DRUG ANTAGONISM; METABOLISM;

APTAMERS, NUCLEOTIDE; BINDING SITES; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CORE BINDING FACTOR BETA SUBUNIT; DNA;

EID: 73349092471     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkp728     Document Type: Article

References (39)

1. Mikhail, F.M., Sinha, K.K., Saunthararajah, Y. and Nucifora, G. (2006) Normal and transforming functions of RUNX1: a perspective. J. Cell Physiol., 207, 582-593.
2. Speck, N.A. (2001) Core binding factor and its role in normal hematopoietic development. Curr. Opin. Hematol., 8, 192-196.
3. Okuda, T., vanDeursen, J., Hiebert, S.W., Grosveld, G. and Downing, J.R. (1996) AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell, 84, 321-330.
4. de Bruijn, M. and Speck, N.A. (2004) Core-binding factors in hematopoiesis and immune function. Oncogene, 23, 4238-4248.
5. Bravo, J., Li, Z., Speck, N.A. and Warren, A.J. (2001) The leukemia-associated AML1 (Runx1)-CBF beta complex functions as a DNA-induced molecular clamp. Nat. Struct. Biol., 8, 371-378.
6. Wang, Q., Stacy, T., Miller, J.D., Lewis, A.F., Gu, T.-L., Huang, X., Bushweller, J.H., Bories, J.-C., Alt, F.W., Ryan, G. et al. (1996) The CBF[beta] subunit is essential for CBF[alpha]2 (AML1) function in vivo. Cell, 87, 697.
7. Kitabayashi, I., Yokoyama, A., Shimizu, K. and Ohki, M. (1998) Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation. EMBO J., 17, 2994-3004.
8. Lutterbach, B., Westendorf, J.J., Linggi, B., Isaac, S., Seto, E. and Hiebert, S.W. (2000) A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia. J. Biol. Chem., 275, 651-656.
9. Petrovick, H.S., Hiebert, S.W., Friedman, A.D., Hetherington, C.J., Tenen, D.G. and Zhang, D.E. (1998) Multiple functional domains of AML1: PU.1 and C/EBP alpha synergize with different regions of AML1. Mol. Cell Biol., 18, 3915-3925.
10. Di Croce, L. (2005) Chromatin modifying activity of leukaemia associated fusion proteins. Hum. Mol. Genet., 14, R77-R84.
11. Follows, G.A., Tagoh, H., Lefevre, P., Hodge, D., Morgan, G.J. and Bonifer, C. (2003) Epigenetic consequences of AML1-ETO action at the human c-FMS locus. EMBO J., 22, 2798-2809.
12. Follows, G.A., Tagoh, H., Richards, S.J., Melnik, S., Dickinson, H., de Wynter, E., Lefevre, P., Morgan, G.J. and Bonifer, C. (2005) c-FMS chromatin structure and expression in normal and leukaemic myelopoiesis. Oncogene, 24, 3643-3651.
13. Roudaia, L., Cheney, M.D., Manuylova, E., Chen, W., Morrow, M., Park, S., Lee, C.T., Kaur, P., Williams, O., Bushweller, J.H. et al. (2009) CBF beta is critical for AML1-ETO and TEL-AML1 activity. Blood, 113, 3070-3079.
14. Ellington, A.D. and Szostak, J. (1990) In vitro selection of RNA molecules that bind specific ligands. Nature, 346, 818-822.
15. Robertson, D.L. and Joyce, G.F. (1990) Selection in vitro of an RNA enzyme that specifically cleaves single-stranded-DNA. Nature, 344, 467-468.
16. Tuerk, C. and Gold, L. (1990) Systematic evolution of ligands by exponential enrichment - RNA ligands to bacteriophage-T4 DNA-polymerase. Science, 249, 505-510.
17. White, R.R., Sullenger, B.A. and Rusconi, C.P. (2000) Developing aptamers into therapeutics J. Clin. Invest., 106, 929934.
18. Wlotzka, B., Leva, S., Eschgfäller, B., Burmeister, J., Kleinjung, F., Kaduk, C., Muhn, P., Hess-Stumpp, H. and Klussmann, S. (2002) In vitro properties of an Anti-GnRH Spiegelmer: An Example of oligonucleotide-based therapeutic substance class. Proc. Natl Acad. Sci. USA, 99, 8898-8902.
19. Ng, E.W.M., Shima, D.T., Calias, P., Emmett, T., Cunningham, J., Guyer, D.R. and Adamis, A.P. (2006) Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat. Rev. Drug Disc., 5, 123-132.
20. Bunka, D.H.J. and Stockley, P.G. (2006) Aptamers come of age - at last. Nat. Rev. Microbiol., 4, 588-596.
21. Park, M.W., Choi, K.H. and Jeong, S. (2005) Inhibition of the DNA binding by the TCF-1 binding RNA aptamer. Biochem. Biophys. Res. Commun., 330, 11-17.
22. Shi, H., Fan, X.C., Sevilimedu, A. and Lis, J.T. (2007) RNA aptamers directed to discrete functional sites on a single protein structural domain. Proc. Natl Acad. Sci. USA, 104, 3742-3746.
23. Zhao, X.C., Shi, H., Sevilimedu, A., Liachko, N., Nelson, H.C.M. and Lis, J.T. (2006) An RNA aptamer that interferes with the DNA binding of the HSF transcription activator. Nucleic Acids Res., 34, 3755-3761.
24. Huang, D.B., Vu, D., Cassiday, L.A., Zimmerman, J.M., Maher, L.J. and Ghosh, G. (2003) Crystal structure of NF-kappa B (p50)(2) complexed to a high-affinity RNA aptamer. Proc. Natl Acad. Sci. USA, 100, 9268-9273.
25. Reiter, N.J., Maher, L.J.I. and Butcher, S.E. (2008) DNA mimicry by a high-affinity anti-NF-{kappa}B RNA aptamer. Nucleic Acids Res., 36, 1227-1236.
26. Murray, J.B., Collier, A.K. and Arnold, J.R.P. (1994) A general purification procedure for chemically synthesized oligoribonucleotides. Anal. Biochem., 218, 177-184.
27. Schuck, P. (2000) Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling. Biophys. J., 78, 1606-1619.
28. Laue, T., Shah, B., Ridgeway, T. and Pelletier, S. (1992) Analytical Ultracentrifugation in Biochemistry and Polymer Science. Royal Society of Chemistry, Cambridge.
29. Warren, A.J., Bravo, J., Williams, R.L. and Rabbitts, T.H. (2000) Structural basis for the heterodimeric interaction between the acute leukaemia-associated transcription factors AML1 and CBF beta. EMBO J., 19, 3004-3015.
30. Bunka, D.H.J., Mantle, B.J., Morten, I.J., Tennent, G.A., Radford, S.E. and Stockley, P.G. (2007) Production and characterization of RNA aptamers specific for amyloid fibril epitopes. J. Biol. Chem., 282, 34500-34509.
31. Ellingham, M., Bunka, D.H.J., Rowlands, D.J. and Stonehouse, N.J. (2006) Selection and characterization of RNA aptamers to the RNA-dependent RNA polymerase from foot-and-mouth disease virus. RNA, 12, 1970-1979.
32. Himes, S.R., Cronau, S., Mulford, C. and Hume, D.A. (2005) The Runx1 transcription factor controls CSF-1-dependent and -independent growth and survival of macrophages. Oncogene, 24, 5278-5286.
33. McGregor, A., Murray, J.B., Adams, C.J., Stockley, P.G. and Connolly, B.A. (1999) Secondary structure mapping of an RNA ligand that has high affinity for the MetJ repressor protein and interference modification analysis of the protein-RNA complex. J. Biol. Chem., 274, 2255-2262.
34. Asou, H., Tashiro, S., Hamamoto, K., Otsuji, A., Kita, K. and Kamada, N. (1991) Establishment of a human acute myeloid-leukemia cell-line (Kasumi-1) with 8-21 chromosome-translocation. Blood, 77, 2031-2036.
35. Tahirov, T.H., Inoue-Bungo, T., Morii, H., Fujikawa, A., Sasaki, M., Kimura, K., Shiina, M., Sato, K., Kumasaka, T., Yamamoto, M. et al. (2001) Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta. Cell, 104, 755-767.
36. Cassiday, L.A., Lebruska, L.L., Benson, L.M., Naylor, S., Owen, W.G. and Maher, L.J. (2002) Binding stoichiometry of an RNA aptamer and its transcription factor target. Anal. Biochem., 306, 290-297.
37. Cassiday, L.A. and Maher, L.J. (2002) Having it both ways: transcription factors that bind DNA and RNA. Nucleic Acids Res., 30, 4118-4126.
38. Gorczynski, M.J., Grembecka, J., Zhou, Y.P., Kong, Y., Roudaia, L., Douvas, M.G., Newman, M., Bielnicka, I., Baber, G., Corpora, T. et al. (2007) Allosteric inhibition of the protein-protein interaction between the leukemia-associated proteins Runx1 and CBF beta. Chem. Biol., 14, 1186-1197.
39. Schneider, D., Tuerk, C. and Gold, L. (1992) Selection of high-affinity RNA ligands to the bacteriophage-R17 coat protein. J. Mol. Biol., 228, 862-869.